Finecare™ 2019-nCoV Antigen Test Antigen testing indicates the active infection of 2019-nCoV. For areas with limited PCR resources, antigen testing can be used for aiding in the diagnosis of COVID-19 suspect patients.

INTENDED USE The Finecare™ 2019-nCoV RBD Antibody Test is a fluorescence immunoassay used along with Finecare™ FIA Meters for qualitative and semi-quantitative detection of spike receptor-binding domain (RBD) antibodies of novel coronaviruses (2019-nCoV) in human fingerstick whole blood, venipuncture whole blood, serum or plasma specimen. The 2019-nCoV RBD antibodies are protective antibody produced by the human body after inoculation with 2019-nCoV vaccine or infection with 2019-nCoV. The test is intended as an aid to assess the adaptive humoral immune response to the 2019-nCoV RBD protein. STORAGE AND STABILITY 1. Store at 4~30°C in the sealed pouch up to the expiration date printed on the package. Do not freeze. 2. The test device should be used within 1 hour after taking out from the foil envelope. 3. Keep away from sunlight, moisture and heat. 4. Kit contents are stable until the expiration date printed on the outer box.

INTENDED USE The Finecare™ 2019-nCoV lgM/lgG Test is a fluorescence immunoassay used along with Finecare™ FIA Meters for qualitative detection of IgG and IgM antibodies of novel coronaviruses (2019-nCoV) in human whole blood, serum and plasma specimen. Clinically, the test is to be used as an aid in the diagnosis of coronavirus infection disease (COVID-19), which is caused by 2019-nCoV. The test provides preliminary test results. Negative results cannot exclude the possibility of 2019-nCoV infection and they cannot be used as the sole basis for treatment or other management decision. STORAGE AND STABILITY 1. Store at 4-30°C in the sealed pouch up to the expiration date printed on the package. Do not freeze. 2. The test device should be used within 1 hour after taking out from the foil envelope. 3. Keep away from sunlight, moisture and heat. 4. Kit contents are stable until the expiration date printed on the outer box.

Intended Use Covid 19 Ag Card Test is designed for in vitro qualitative detection of Covid 19 antigen in human nasopharyngeal, nasal swab specimens. The kit is intended for professional use and as a screening test and is an aid in early diagnosis of SARS COV-2 infection in patients with clinical symptoms. Salient Features Rapid Visual Test for the Qualitative Detection of Covid-19 (SARS-COV-2) antigen in Human nasopharyngeal and nasal swab specimens. Based on Sandwich Immunoassay principle. Results within 20 minutes. Single step test procedure. Evaluated & Validated by ICMR Centre ; Sensitivity -91.5% (<30 CT) & Specificity -100% against RT-PCR. Long Shelf life:30 months at 2-30° C. No Instruments required. Convenient pack sizes . 10T,25T,50T,100T & 200T.

STANDARD Q COVID-19 Ag STANDARD Q COVID-19 Ag Test is a rapid chromatographic immunoassay for the qualitative detection of nucleocapsid antigens to SARS-CoV-2 present in human nasopharynx

At Mindray we pride ourselves on our dedication and experience in developing better solutions for small labs. Our new line of 3-part hematology analyzers is the culmination of that effort. Compact yet powerful, full featured yet affordable, the BC-20s is what a 3-part analyzer should be. Features CBC+3-DIFF, 19 parameters+3 histograms Throughput:40 samples per hour Intuitive operation system with 8.4 inch TFT touch screen Open vial sampling 200,000 results storage with histograms Original QC, calibrators and reagents Product Specification Instrument Name Haematology Analyzer Model Name/Number BC20s Usage/Application Laboratory Brand Mindray Automation Fully Automatic Operation Mode Fully Automatic

Based on Mindray’s continuous innovation in hematology field, BC-5130 is especially tailored to assist diagnostic labs who need full CBC + 5-part results, with relatively low daily sample volume, restricted lab space and tight budget. As the lightest and most compact 5-part hematology analyzer so far from Mindray, BC-5130 is a highly user-friendly and innovative analyzer that offers cost efficient CBC and 5-part white cell differential results. It is targeted to fulfill and exceed the demands of our global customers by providing more accurate, more efficient and more innovative solutions for labs. Improved DC impedance technology is used to count and size the RBC and PLT. The smaller counting aperture (50 μm in diameter) provides better performance on samples with low PLT. Efficient Only three routine reagents are required. These have 2 years shelf life and also less consumed by BC-5130. Original QC and calibrator are also provided to ensure the hematology analyzer’s traceability and testing quality. WBC 5-Part differentiation,25 reportable parameters & 23 research parameters,3 histograms Whole blood Mode, Capillary whole blood mode & Prediluted Mode Tri-angle Laser Scatter + Chemical dye + Flow cytometry technology Dedicated optical counting channel for Basophil measurement 10.4 inch large TFT touch screen with user-friendly software Large storage capacity: Up to 1,50,000 samples Throughput:60 samples/Hour Compact Two kinds of lyse reagents are located inside of BC-5130, which helps the small labs to save space. BC-5130, the 5-part hematology analyzer offers a great solution for clinical labs, especially for those who have limited space. Its compact foot-print is a result of innovative technology improvements, including miniaturized semi-conductor laser source, highly integrated electronic boards and optimized liquid handling system. BC-5130 inherits it’s convenient and proven powerful software design from BC-6800 and BC-3600 platforms, the friendly interface is ideal for small sized labs. Running capillary blood through the sample probe directly is more convenient for the users in children’s hospitals, etc. For Prediluted mode, BC-5130 has higher dilution ratio than other 5-part hematology There’s NLR parameter in each CBC+DIFF result. Neutrophil-to-lymphocyte ratio (NLR) is calculated by dividing neutrophil count by lymphocyte count, usually from peripheral blood sample. In laboratory medicine, NLR is used as a marker of subclinical inflammation. According to clinical studies, NLR can be used as a prognostic factor of severe illness in COVID-19 patients. BC-5130 supports bi-directional LIS with test results and patient information. HL7 protocol is supported as well. Technology Compared with traditional helium neon laser or argon laser, semi -conductor laser has smaller size, lower cost and longer life cycle.

In compliance with out-of-hospital patient transport standards such as EN1789, EN13718-1, IEC60601-1-12 and U.S. military standards, N1 is a highly competent solution for various out-of-hospital transport settings both on land and in air. The N1's exceptional reliability and strong performance enhance your confidence to provide seamless patient care during transport no matter intra or out of hospital. One monitor, Multiple solutions Mirror Mode Two-way screen or remote control functionality and viewing on both the 19" external display and the N1 unit - simultaneously. benevision-n1-fig2-2-pc BeneVision N1 as a Transport Monitor Enhanced data analysis greatly improves parameters' accuracy and anti-interference ability. Its fully integrated sidestream CO2 module monitors the patient's breathing situation by connecting with sampling line directly, freeing caregivers from the shackles of expanding external modules for transport. One monitor, Multiple solutions Mirror Mode Two-way screen or remote control functionality and viewing on both the 19" external display and the N1 unit - simultaneously. benevision-n1-fig2-2-pc BeneVision N1 as a Transport Monitor Enhanced data analysis greatly improves parameters' accuracy and anti-interference ability. Its fully integrated sidestream CO2 module monitors the patient's breathing situation by connecting with sampling line directly, freeing caregivers from the shackles of expanding external modules for transport. benevision-n1-fig2-1-pc BeneVision N1 as a Multi-Parameter Module Slide directly into the module slot or SMR of the N-Series monitor providing an expansive set of parameter measurements. When combined with our additional advanced parameter modules, this solution fits even the highest level of critical care environments. benevision-n1-fig2-3-pc Companion Mode Connect with N-Series host monitor via cable connection to N1 dock and have the ability for dual-screen monitoring and bi-directional control of the bedside monitor - expanding slot space for more advanced parameters and enhanced ICU workflow. Patient-Centric Data Collection When connected to a bedside patient monitor, advanced parameters collected from the host monitor such as AG and BIS, etc., will also be stored in N1 with trend data and alarm events reviewable even when it is disconnected.

Mindray believes the best way to predict the future is to create it. The revolutionary BeneVision N22/N19 is designed to optimize user experience by satisfying all your clinical demands. With visionary-stimulating design, benchmarking ease of use, confidence-maximizing innovations and workflow-transforming interoperability, BeneVision N22/N19 is creating tomorrow’s monitoring perspective today. The design excellence of BeneVision N22/N19 has great originality to lead your perspective. A seamless outlook optimizes your monitoring experience with super large touchscreen, cool rotatable landscape & portrait layout, ultra slim main unit as well as plug-n-play modules. An ingenious user interface including multi-window flat menus, infographic alarm indications and online user guide offers extremely intuitive patient data and ultimate ease-of-use, while auto screen brightness always keeps patient in mind. Benefitting from cutting-edge clinical measurements, such as rSO2, ICG, PiCCO, AG, RM, BIS, NMT, and state-of-art clinical decision support tools, such as HemoSightTM, ST GraphicTM, DSA, BeneVision N22/N19 enhances your clinical confidence to the max and helps you make easier and faster clinical decisions. The connectivity capabilities of BeneVision N22/N19 fit seamlessly into your clinical workflow for paperless future. Revolutionary iView clinical informatics workstation brings all intelligence (PACS, LIS, EMR, etc) on screen at point of care for one-stop diagnosis. Industry-leading BeneLink integrates all bedside devices to the monitor realtimely and facilitates centralized data management.